123 related articles for article (PubMed ID: 36774689)
1. Glyoxalase 1 inhibitor BBGC suppresses the progression of chronic lymphocytic leukemia and promotes the efficacy of Palbociclib.
Tang J; Zhong J; Yang Z; Su Q; Mo W
Biochem Biophys Res Commun; 2023 Apr; 650():96-102. PubMed ID: 36774689
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells.
Sakamoto H; Mashima T; Sato S; Hashimoto Y; Yamori T; Tsuruo T
Clin Cancer Res; 2001 Aug; 7(8):2513-8. PubMed ID: 11489834
[TBL] [Abstract][Full Text] [Related]
3. Glyoxalase I is involved in resistance of human leukemia cells to antitumor agent-induced apoptosis.
Sakamoto H; Mashima T; Kizaki A; Dan S; Hashimoto Y; Naito M; Tsuruo T
Blood; 2000 May; 95(10):3214-8. PubMed ID: 10807791
[TBL] [Abstract][Full Text] [Related]
4. GLO1-A novel amplified gene in human cancer.
Santarius T; Bignell GR; Greenman CD; Widaa S; Chen L; Mahoney CL; Butler A; Edkins S; Waris S; Thornalley PJ; Futreal PA; Stratton MR
Genes Chromosomes Cancer; 2010 Aug; 49(8):711-25. PubMed ID: 20544845
[TBL] [Abstract][Full Text] [Related]
5. STAT3-induced SMYD3 transcription enhances chronic lymphocytic leukemia cell growth in vitro and in vivo.
Lin F; Wu D; Fang D; Chen Y; Zhou H; Ou C
Inflamm Res; 2019 Sep; 68(9):739-749. PubMed ID: 31218443
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic effect of palbociclib in chondrosarcoma: implication of cyclin-dependent kinase 4 as a potential target.
Ouyang Z; Wang S; Zeng M; Li Z; Zhang Q; Wang W; Liu T
Cell Commun Signal; 2019 Feb; 17(1):17. PubMed ID: 30808351
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of NF-κB-mediated signaling by the cyclin-dependent kinase inhibitor CR8 overcomes prosurvival stimuli to induce apoptosis in chronic lymphocytic leukemia cells.
Cosimo E; McCaig AM; Carter-Brzezinski LJ; Wheadon H; Leach MT; Le Ster K; Berthou C; Durieu E; Oumata N; Galons H; Meijer L; Michie AM
Clin Cancer Res; 2013 May; 19(9):2393-405. PubMed ID: 23532892
[TBL] [Abstract][Full Text] [Related]
8. Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia.
Maharaj K; Powers JJ; Achille A; Deng S; Fonseca R; Pabon-Saldana M; Quayle SN; Jones SS; Villagra A; Sotomayor EM; Sahakian E; Pinilla-Ibarz J
Blood Adv; 2018 Nov; 2(21):3012-3024. PubMed ID: 30425065
[TBL] [Abstract][Full Text] [Related]
9. Anti-cell growth and anti-cancer stem cell activity of the CDK4/6 inhibitor palbociclib in breast cancer cells.
Kishino E; Ogata R; Saitoh W; Koike Y; Ohta Y; Kanomata N; Kurebayashi J
Breast Cancer; 2020 May; 27(3):415-425. PubMed ID: 31823286
[TBL] [Abstract][Full Text] [Related]
10. CDK4/6 inhibitor palbociclib overcomes acquired resistance to third-generation EGFR inhibitor osimertinib in non-small cell lung cancer (NSCLC).
Qin Q; Li X; Liang X; Zeng L; Wang J; Sun L; Zhong D
Thorac Cancer; 2020 Sep; 11(9):2389-2397. PubMed ID: 32677256
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CDK4 sensitizes multidrug resistant ovarian cancer cells to paclitaxel by increasing apoptosiss.
Gao Y; Shen J; Choy E; Mankin H; Hornicek F; Duan Z
Cell Oncol (Dordr); 2017 Jun; 40(3):209-218. PubMed ID: 28243976
[TBL] [Abstract][Full Text] [Related]
12. Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.
Long Q; Ma AH; Zhang H; Cao Z; Xia R; Lin TY; Sonpavde GP; de Vere White R; Guo J; Pan CX
Cancer Immunol Immunother; 2020 Nov; 69(11):2305-2317. PubMed ID: 32506263
[TBL] [Abstract][Full Text] [Related]
13. Chrysin induces apoptosis in peripheral blood lymphocytes isolated from human chronic lymphocytic leukemia.
Zaric M; Mitrovic M; Nikolic I; Baskic D; Popovic S; Djurdjevic P; Milosavljevic Z; Zelen I
Anticancer Agents Med Chem; 2015; 15(2):189-95. PubMed ID: 25257897
[TBL] [Abstract][Full Text] [Related]
14. Glyoxalase 1: Emerging biomarker and therapeutic target in cervical cancer progression.
Kim JY; Jung JH; Jung S; Lee S; Lee HA; Ouh YT; Hong SH
PLoS One; 2024; 19(6):e0299345. PubMed ID: 38870176
[TBL] [Abstract][Full Text] [Related]
15. Palbociclib synergizes with BRAF and MEK inhibitors in treatment naïve melanoma but not after the development of BRAF inhibitor resistance.
Martin CA; Cullinane C; Kirby L; Abuhammad S; Lelliott EJ; Waldeck K; Young RJ; Brajanovski N; Cameron DP; Walker R; Sanij E; Poortinga G; Hannan RD; Pearson RB; Hicks RJ; McArthur GA; Sheppard KE
Int J Cancer; 2018 May; 142(10):2139-2152. PubMed ID: 29243224
[TBL] [Abstract][Full Text] [Related]
16. Expression and regulation of CacyBP/SIP in chronic lymphocytic leukemia cell balances of cell proliferation with apoptosis.
Fu C; Wan Y; Shi H; Gong Y; Wu Q; Yao Y; Niu M; Li Z; Xu K
J Cancer Res Clin Oncol; 2016 Apr; 142(4):741-8. PubMed ID: 26603518
[TBL] [Abstract][Full Text] [Related]
17. Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
Rabbani N; Thornalley PJ
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269594
[TBL] [Abstract][Full Text] [Related]
18. Combined CDK4/6 and Pan-mTOR Inhibition Is Synergistic Against Intrahepatic Cholangiocarcinoma.
Song X; Liu X; Wang H; Wang J; Qiao Y; Cigliano A; Utpatel K; Ribback S; Pilo MG; Serra M; Gordan JD; Che L; Zhang S; Cossu A; Porcu A; Pascale RM; Dombrowski F; Hu H; Calvisi DF; Evert M; Chen X
Clin Cancer Res; 2019 Jan; 25(1):403-413. PubMed ID: 30084835
[TBL] [Abstract][Full Text] [Related]
19. ABT-737 resistance in B-cells isolated from chronic lymphocytic leukemia patients and leukemia cell lines is overcome by the pleiotropic kinase inhibitor quercetin through Mcl-1 down-regulation.
Russo M; Spagnuolo C; Volpe S; Tedesco I; Bilotto S; Russo GL
Biochem Pharmacol; 2013 Apr; 85(7):927-36. PubMed ID: 23353698
[TBL] [Abstract][Full Text] [Related]
20. Expression and regulation of COP1 in chronic lymphocytic leukemia cells for promotion of cell proliferation and tumorigenicity.
Fu C; Gong Y; Shi X; Shi H; Wan Y; Wu Q; Xu K
Oncol Rep; 2016 Mar; 35(3):1493-500. PubMed ID: 26717976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
